SMR TT Augmented 360 MB
AUGMENT your optionsSMR TT Augmented 360 MB aims at supporting surgeons to treat any glenoid bone loss case with a modular, defect-matching solution.
Video
Images
About
A circular baseplate design paired with a modular clinically proven TT peg [4-6] and prepared on-axis with the new ASAP Reamer & Drill System.
SMR TT Augmented 360 MB aims at supporting surgeons to treat any glenoid bone loss case with a modular, defect-matching solution. ASAP system aims at increasing reproducibility and at reducing intraoperative time, while TT aim at ensuring a long-term fixation, proven by its long clinical heritage [4-9].
See bibliography
[1] Kirsch JM, Khan M, Thornley P, Gichuru M, Freehill MT, Neviaser A, Moravek J, Miller BS, Bedi A. Platform shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg. 2018;27(4):756-3.
[2] Weber-Spickschen TS, Alfke D, Agneskirchner JD. The use of a modular system to convert an anatomical total shoulder arthroplasty to a reverse shoulder arthroplasty: Clinical and radiological results. Bone Joint J. 2015 Dec;97-B(12):1662-7
[3] Castagna A, Delcogliano M, de Caro F, Ziveri G, Borroni M, Gumina S, Postacchini F, De Biase CF. Conversion of shoulder arthroplasty to reverse implants: clinical and radiological results using a modular system. Int Orthop. 2013 Jul;37(7):1297-305.
[4] Granville-Chapman J, Copas D, Robinson S, Walton M, Bale RS, Trail IA. The First Series of SMR AXIOMA-TT Early Experiences with an Innovative Trabecular Titanium Implant for Complex Glenoid Reconstruction. Shoulder & Elbow 2015;7(4):318-9.
[5] A. M. Malhas, J. Granville-Chapman, P. M. Robinson, S. Brookes-Fazakerley, M. Walton, P. Monga, S. Bale, I. Trail Reconstruction of the glenoid using autologous bone-graft and the SMR Axioma TT metal-backed prosthesis. Bone Joint J 2018;100-B:1609–17.
[6] Singh J et al. Survivorship of Autologous Structural Bone Graft at a Minimum of Two Years when used to address Significant Glenoid Bone Loss In Primary and Revision Shoulder Arthroplasty: A CT and clinical Review. J Shoulder Elbow Surg. Epub 2020 Jul.
[7]* Marin E, Fedrizzi L, Regis M, Pressacco M, Zagra L, Fusi S. Stability Enhancement Of Prosthetic Implants: Friction Analysis Of Trabecular
Titanium. Hip Int. 2012;403:427-8.
[8]* Sollazzo V, Massari L, Pezzetti F, Girardi A, Farinella F, Lorusso V, Burelli S, Bloch HR, Carinci F. Genetic effects of Trabecular Titanium™ on MG-63 cell line: a genetic profiling evaluation. ISRN Mater Sci. 2011:392763.
[9]* Benazzo F, Botta L, Scaffino MF, Caliogna L, Marullo M, Fusi S, Gastaldi G. Trabecular Titanium can induce in vitro osteogenic differentiation of human
adipose derived stem cells without osteogenic factors. J Biomed Mater Res
Part A. 2014:102A:2061–71.
[10]* Devine D, Arens D, Burelli S, Bloch HR, Boure L. In vivo evaluation of the osteointegration of new highly porous Trabecular Titanium™. J Bone Joint Surg Br. 2012;94-B(Suppl XXXVII):201.
*results from pre-clinical studies only.
[2] Weber-Spickschen TS, Alfke D, Agneskirchner JD. The use of a modular system to convert an anatomical total shoulder arthroplasty to a reverse shoulder arthroplasty: Clinical and radiological results. Bone Joint J. 2015 Dec;97-B(12):1662-7
[3] Castagna A, Delcogliano M, de Caro F, Ziveri G, Borroni M, Gumina S, Postacchini F, De Biase CF. Conversion of shoulder arthroplasty to reverse implants: clinical and radiological results using a modular system. Int Orthop. 2013 Jul;37(7):1297-305.
[4] Granville-Chapman J, Copas D, Robinson S, Walton M, Bale RS, Trail IA. The First Series of SMR AXIOMA-TT Early Experiences with an Innovative Trabecular Titanium Implant for Complex Glenoid Reconstruction. Shoulder & Elbow 2015;7(4):318-9.
[5] A. M. Malhas, J. Granville-Chapman, P. M. Robinson, S. Brookes-Fazakerley, M. Walton, P. Monga, S. Bale, I. Trail Reconstruction of the glenoid using autologous bone-graft and the SMR Axioma TT metal-backed prosthesis. Bone Joint J 2018;100-B:1609–17.
[6] Singh J et al. Survivorship of Autologous Structural Bone Graft at a Minimum of Two Years when used to address Significant Glenoid Bone Loss In Primary and Revision Shoulder Arthroplasty: A CT and clinical Review. J Shoulder Elbow Surg. Epub 2020 Jul.
[7]* Marin E, Fedrizzi L, Regis M, Pressacco M, Zagra L, Fusi S. Stability Enhancement Of Prosthetic Implants: Friction Analysis Of Trabecular
Titanium. Hip Int. 2012;403:427-8.
[8]* Sollazzo V, Massari L, Pezzetti F, Girardi A, Farinella F, Lorusso V, Burelli S, Bloch HR, Carinci F. Genetic effects of Trabecular Titanium™ on MG-63 cell line: a genetic profiling evaluation. ISRN Mater Sci. 2011:392763.
[9]* Benazzo F, Botta L, Scaffino MF, Caliogna L, Marullo M, Fusi S, Gastaldi G. Trabecular Titanium can induce in vitro osteogenic differentiation of human
adipose derived stem cells without osteogenic factors. J Biomed Mater Res
Part A. 2014:102A:2061–71.
[10]* Devine D, Arens D, Burelli S, Bloch HR, Boure L. In vivo evaluation of the osteointegration of new highly porous Trabecular Titanium™. J Bone Joint Surg Br. 2012;94-B(Suppl XXXVII):201.
*results from pre-clinical studies only.
Resources
Disclaimer
Please note that not all products are available and registered in every market. Please contact your LimaCorporate Sales Representative for any further information.
BioBall® System is manufactured by Merete GmbH and distributed by Lima France sas.
DiPHOS Nail is manufactured by LSM-MED S.r.l. and distributed by Lima France sas.
BIOLOX® / BIOLOX®delta / BIOLOX OPTION® is a registered trademark of a company of the CeramTec Group, Germany.
BioBall® System is manufactured by Merete GmbH and distributed by Lima France sas.
DiPHOS Nail is manufactured by LSM-MED S.r.l. and distributed by Lima France sas.
BIOLOX® / BIOLOX®delta / BIOLOX OPTION® is a registered trademark of a company of the CeramTec Group, Germany.